Zimmer Biomet Holdings, Inc.
ZBH
$86.69
$1.712.01%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -16.66% | -21.98% | -25.68% | -17.41% | -5.24% |
| Total Depreciation and Amortization | 9.61% | 9.79% | 10.22% | 7.93% | 5.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.77% | -94.33% | 456.00% | 3,483.33% | 635.48% |
| Change in Net Operating Assets | 35.53% | 76.97% | 51.51% | 44.63% | 25.73% |
| Cash from Operations | 1.18% | 13.19% | 6.61% | 9.16% | 10.14% |
| Capital Expenditure | -29.88% | -18.22% | 0.64% | 22.27% | 32.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -404.23% | -404.23% | -535.04% | -752.28% | -138.19% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 9.15% | 65.71% | 32.22% | 33.22% | -13.66% |
| Cash from Investing | -153.87% | -122.46% | -137.85% | -133.76% | 3.08% |
| Total Debt Issued | -76.11% | 73.51% | 169.08% | 600.17% | 765.59% |
| Total Debt Repaid | 65.97% | -62.56% | -382.54% | -442.46% | -442.46% |
| Issuance of Common Stock | -16.75% | -51.64% | -61.84% | -64.85% | -65.10% |
| Repurchase of Common Stock | 48.46% | 43.89% | 74.36% | -48.49% | -82.87% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 2.57% | 2.91% | 3.73% | 3.31% | 2.80% |
| Other Financing Activities | -36.39% | -68.38% | -94.82% | -139.93% | -196.80% |
| Cash from Financing | -538.72% | 167.29% | 298.34% | 167.31% | 123.23% |
| Foreign Exchange rate Adjustments | 397.73% | 211.11% | -98.81% | 359.62% | 42.86% |
| Miscellaneous Cash Flow Adjustments | 200.00% | -- | -- | -- | -- |
| Net Change in Cash | -196.85% | -39.47% | 161.32% | 36.16% | 1,478.82% |